Supriya Lifescience Limited Announces 18th AGM on Sep 24, 2026
Supriya Lifescience Limited will hold its 18th Annual General Meeting (AGM) on September 24, 2026, at 3:00 p.m. IST via Video Conferencing (VC) / Other Audio Visual Means (OAVM). This announcement complies with SEBI regulations and MCA circulars.
The announcement is a standard procedural update about the AGM date and method of conduct. It does not involve any new business, financial results, or strategic decisions that would significantly impact the company's operations or stock price.
The announcement is a routine regulatory filing regarding the Annual General Meeting and does not contain any financial or operational performance updates that would indicate a positive or negative sentiment.
Supriya Lifescience Limited has announced that its 18th Annual General Meeting (AGM) will be held on Thursday, September 24, 2026, at 3:00 p.m. IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
The company has published this information in compliance with applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and relevant circulars issued by the Ministry of Corporate Affairs. Copies of the newspaper advertisements published in The Financial Express (English) and Loksatta (Marathi) have been provided.
Further details regarding the AGM, including the Notice of the AGM and the Annual Report for FY 2025-26, will be disseminated electronically to members who have registered their email addresses. The company aims to ensure compliance with regulatory requirements while facilitating shareholder participation.
What to do with a filing like this
Supriya Lifescience Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Supriya Lifescience Limited. Read the original for the full detail.